MolDrug
MolDrug AI Systems specializes in computational chemistry and molecular modeling technologies for drug discovery. They offer advanced AI solutions for drug design, molecular docking, metabolomics, and gene expression analysis. Their key products include G4-QuadScreen for identifying Multi-Target Directed Ligands and PeptiKinetics for predicting pharmacokinetic behavior of peptides. With a focus on innovative methodologies, they aim to enhance drug development processes and improve therapeutic outcomes in various diseases.
MolDrug
MolDrug AI Systems specializes in computational chemistry and molecular modeling technologies for drug discovery. They offer advanced AI solutions for drug design, molecular docking, metabolomics, and gene expression analysis. Their key products include G4-QuadScreen for identifying Multi-Target Directed Ligands and PeptiKinetics for predicting pharmacokinetic behavior of peptides. With a focus on innovative methodologies, they aim to enhance drug development processes and improve therapeutic outcomes in various diseases.
TL;DR
Headquarters: Valencia, Spain
Founded: 2018
Focus: Computational chemistry, molecular modelling, structure-based drug design
Key products: G4-QuadScreen, PeptiKinetics
Team size (reported): 4 employees
Company Overview
Problem Domain
Drug discovery and cheminformatics
Founded
2018
Industry
Biotechnology